SCHEMBL1911864

SCHEMBL1911864

COc1ccc(C)c(OC)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.52
TDP1 Q9NUW8 1/20 0.52
CYP1A2 P05177 1/20 0.46
KMT2A Q03164 1/20 0.46
RECQL P46063 1/20 0.46
NNMT P40261 1/20 0.41
PDE10A Q9Y233 5/20 0.41
BRD9 Q9H8M2 2/20 0.40
BRD7 Q9NPI1 2/20 0.40
RAB9A P51151 2/20 0.38
NPC1 O15118 1/20 0.38
SIRT2 Q8IXJ6 1/20 0.37
SIRT1 Q96EB6 1/20 0.37
HPGD P15428 2/20 0.36
TSHR P16473 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HSD17B10 Q99714 2/20 0.36
ERN1 O75460 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21585396 0.81 POLB (0.37) POLBTDP1RECQLPDE10ASMN1; SMN2
SCHEMBL31546798 0.79 RECQL (0.36) POLBTDP1CYP1A2KMT2ARECQL
SCHEMBL18952434 0.78 POLB (0.54) POLBTDP1CYP1A2KMT2ARECQL
SCHEMBL10075373 0.78 APOBEC3A (0.42) POLBCYP1A2KMT2ARAB9ANPC1
SCHEMBL17276010 0.78 BRD9 (0.56) POLBTDP1CYP1A2KMT2ARECQL
SCHEMBL172558 0.78 NNMT (0.52) POLBTDP1CYP1A2KMT2ANNMT
SCHEMBL31438401 0.78 BRD9 (0.56) POLBTDP1CYP1A2KMT2ARECQL
SCHEMBL22621616 0.76 POLB (0.52) POLBTDP1CYP1A2KMT2ARECQL
SCHEMBL25009545 0.76 POLB (0.37) POLBTDP1CYP1A2KMT2ARECQL
SCHEMBL22198926 0.76 HAO1 (0.44) POLBKMT2ATSHRMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 251 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11771738-B2 Endoparasitic depsipeptides ZOETIS SERVICES LLC (US) 2023-10-03 US disclosed
US-11771738-B2 Endoparasitic depsipeptides ZOETIS SERVICES LLC (US) 2023-10-03 US disclosed
US-20230303611-A1 SYNTHESIS OF AN ANTIVIRAL AZASUGAR TRIPHOSPHATE WILMINGTON TRUST, NATIONAL ASSOCIATION 2023-09-28 US disclosed
US-20230303611-A1 SYNTHESIS OF AN ANTIVIRAL AZASUGAR TRIPHOSPHATE WILMINGTON TRUST, NATIONAL ASSOCIATION 2023-09-28 US disclosed
WO-2023014908-A1 LPAR1 ANTAGONISTS AND USES THEREOF Pipeline Therapeutics, Inc. (US) 2023-02-09 WO disclosed
EP-3802517-B1 ALKOXY-SUBSTITUTED PYRIDINYL DERIVATIVES AS LPA1 RECEPTOR ANTAGONISTS AND THEIR USE IN THE TREATMENT OF FIBROSIS IDORSIA PHARMACEUTICALS LTD (CH) 2022-12-21 EP disclosed
US-11530175-B2 Method for preparation of fluoro alkylated compounds by homogeneous Ni catalysis ARXADA AG (CH) 2022-12-20 US disclosed
US-20220041530-A1 Method for Preparation of Fluoro Alkylated Compounds by Homogeneous NI Catalysis LONZA LTD (CH) 2022-02-10 US disclosed
WO-2021183762-A1 IMMUNOMODULATING O-HET-ARYL AZALIDES ZOETIS SERVICES LLC (US) 2021-09-16 WO disclosed
US-20210246116-A1 ALKOXY-SUBSTITUTED PYRIDINYL DERIVATIVES AS LPA1 RECEPTOR ANTAGONISTS AND THEIR USE IN THE TREATMENT OF FIBROSIS IDORSIA PHARMACEUTICALS LTD (CH) 2021-08-12 US disclosed
US-7169789-B2 Quinoline derivatives and quinazoline derivatives KIRIN BEER KABUSHIKI KAISHA (JP) 2007-01-30 US disclosed
US-7169789-B2 Quinoline derivatives and quinazoline derivatives KIRIN BEER KABUSHIKI KAISHA (JP) 2007-01-30 US disclosed
US-7160900-B2 Tetrahydropyridino or piperidino heterocyclic derivatives TAISHO PHARMACEUTICAL CO., LTD. (JP) 2007-01-09 US disclosed
WO-2006070192-A1 THIAZOLE AND ISOTHIAZOLE DERIVATIVES THAT MODULATE THE ACIVITY OF CDK, GSK AND AURORA KYNASES ASTEX THERAPEUTICS LIMITED (GB) 2006-07-06 WO disclosed
WO-2005007621-A2 UBIQUITIN LIGASE INHIBITORS RIGEL PHARMACEUTICALS, INC. (US) 2005-01-27 WO disclosed
WO-2005002552-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS PROTEIN KINASES INHIBITORS ASTEX THERAPEUTICS LIMITED (GB) 2005-01-13 WO disclosed
US-5157018-A Phenolic resins; for waterless offset printing plates HOECHST AKTIENGESELLSCHAFT (DE) 1992-10-20 US disclosed
US-5104961-A Waterless offset printing HOECHST CELANESE CORPORATION (US) 1992-04-14 US disclosed
US-5006443-A Radiation sensitive reproduction composition and element with perfluoroalkyl group containing polymer HOECHST AKTIENGESELLSCHAFT (DE) 1991-04-09 US disclosed
EP-0164059-A2 Polymers having perfluoroalkyl groups, reproducing layers containing them, and their use in non-aqueous offset printing HOECHST AKTIENGESELLSCHAFT (DE) 1985-12-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220041530-A1 Method for Preparation of Fluoro Alkylated Compounds by Homogeneous NI Catalysis ABL1, AFF2, NAF1 POLB 838/4885TDP1 2062/4885CYP1A2 172/4885
US-11530175-B2 Method for preparation of fluoro alkylated compounds by homogeneous Ni catalysis ABL1, AFF2, NAF1 POLB 838/4885TDP1 2062/4885CYP1A2 172/4885
US-11771738-B2 Endoparasitic depsipeptides VIP, PREP, VIPR1 POLB 4515/4885TDP1 3426/4885CYP1A2 1888/4885
US-20210246116-A1 ALKOXY-SUBSTITUTED PYRIDINYL DERIVATIVES AS LPA1 RECEPTOR ANTAGONISTS AND THEIR USE IN THE TREATMENT OF FIBROSIS LPAR1, LPAR3, LPAR2 POLB 3402/4885TDP1 3521/4885CYP1A2 899/4885
US-20230303611-A1 SYNTHESIS OF AN ANTIVIRAL AZASUGAR TRIPHOSPHATE RNGTT, ADAR, MTAP POLB 152/4885TDP1 947/4885CYP1A2 1893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.